Cite
MLA Citation
Luis Sánchez-Trujillo et al.. “Phase II clinical trial testing the safety of a humanised monoclonal antibody anti-CD20 in patients with heart failure with reduced ejection fraction, ICFEr-RITU2: study protocol.” BMJ open, vol. 9, no. 3, 2019, p. . http://access.bl.uk/ark:/81055/vdc_100135182475.0x000004